↓ Skip to main content

Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience

Overview of attention for article published in Frontiers in Cardiovascular Medicine, February 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Transitioning From Preclinical Evidence to Advanced Therapy Medicinal Product: A Spanish Experience
Published in
Frontiers in Cardiovascular Medicine, February 2021
DOI 10.3389/fcvm.2021.604434
Pubmed ID
Authors

Paloma Gastelurrutia, Cristina Prat-Vidal, Joaquim Vives, Ruth Coll, Antoni Bayes-Genis, Carolina Gálvez-Montón

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 21%
Student > Master 5 15%
Student > Doctoral Student 3 9%
Student > Ph. D. Student 2 6%
Student > Bachelor 1 3%
Other 2 6%
Unknown 13 39%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 6 18%
Agricultural and Biological Sciences 3 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Nursing and Health Professions 2 6%
Business, Management and Accounting 1 3%
Other 5 15%
Unknown 14 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2021.
All research outputs
#15,614,503
of 23,277,141 outputs
Outputs from Frontiers in Cardiovascular Medicine
#2,625
of 7,176 outputs
Outputs of similar age
#305,409
of 506,233 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#117
of 269 outputs
Altmetric has tracked 23,277,141 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,176 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 506,233 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 269 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.